ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CGEM Cullinan Therapeutics Inc

27.89
-0.21 (-0.75%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cullinan Therapeutics Inc CGEM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.21 -0.75% 27.89 09:29:53
Open Price Low Price High Price Close Price Previous Close
28.22 26.73 28.22 27.58 28.10
more quote information »

Recent News

Date Time Source Heading
29/4/202421:00GLOBECullinan Therapeutics Announces Appointment of Mary Kay..
25/4/202400:09GLOBECullinan Therapeutics to Present Clinical Data from Phase 1..
16/4/202421:00GLOBECullinan Therapeutics Announces Strategic Expansion into..
16/4/202420:59GLOBECullinan Therapeutics Announces Oversubscribed $280 million..
14/3/202422:00GLOBECullinan Oncology Provides Corporate Update and Reports..
01/3/202423:00GLOBECullinan Oncology Announces U.S. FDA Clearance of..
28/2/202400:00GLOBECullinan Oncology to Participate in Upcoming Investor..
24/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202413:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/2/202413:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:43EDGAR2Form 144 - Report of proposed sale of securities
31/1/202411:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202408:27EDGAR2Form 144 - Report of proposed sale of securities
25/1/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202408:18EDGAR2Form 144 - Report of proposed sale of securities
09/1/202408:15EDGAR2Form 8-K/A - Current report: [Amend]
09/1/202401:12EDGAR2Form 8-K - Current report
23/12/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202309:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202308:53GLOBECullinan Oncology to Present at the 42nd Annual J.P. Morgan..
15/12/202308:30GLOBECullinan Oncology Announces First Patient Dosed in Phase 1..
14/12/202312:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202312:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202323:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202323:10EDGAR2Form 8-K - Current report
08/11/202323:00GLOBECullinan Oncology Provides Corporate Update and Reports..
04/11/202303:01GLOBECullinan Oncology to Present Data Demonstrating Progress..
30/10/202323:00GLOBECullinan Oncology to Participate in Upcoming Investor..
06/9/202322:00GLOBECullinan Oncology to Participate in Upcoming Investor..
10/8/202321:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202321:07EDGAR2Form 8-K - Current report
10/8/202321:00GLOBECullinan Oncology Provides Corporate Update and Reports..
09/8/202321:00GLOBECullinan Oncology Announces First Patient Dosed in Phase 1..
04/8/202306:15PRNUSREZILIENT3 Global First-Line Trial of Zipalertinib Launched..
31/7/202322:00GLOBECullinan Oncology to Participate in Upcoming Investor..
06/7/202311:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/5/202307:00GLOBECullinan Oncology to Present First Monotherapy Clinical Data..
12/5/202306:01GLOBECullinan Oncology Provides Corporate Update and Reports..

Your Recent History

Delayed Upgrade Clock